TY - JOUR
T1 - Clinical prediction of functional outcome after ischemic stroke the surprising importance of periventricular white matter disease and race
AU - Kissela, Brett
AU - Lindsell, Christopher J.
AU - Kleindorfer, Dawn
AU - Alwell, Kathleen
AU - Moomaw, Charles J.
AU - Woo, Daniel
AU - Flaherty, Matthew L.
AU - Air, Ellen
AU - Broderick, Joseph
AU - Tsevat, Joel
PY - 2009/2
Y1 - 2009/2
N2 - Background and Purpose-We sought to build models that address questions of interest to patients and families by predicting short-and long-term mortality and functional outcome after ischemic stroke, while allowing for risk restratification as comorbid events accumulate. Methods-A cohort of 451 ischemic stroke subjects in 1999 were interviewed during hospitalization, at 3 months, and at approximately 4 years. Medical records from the acute hospitalization were abstracted. All hospitalizations for 3 months poststroke were reviewed to ascertain medical and psychiatric comorbidities, which were categorized for analysis. Multivariable models were derived to predict mortality and functional outcome (modified Rankin Scale) at 3 months and 4 years. Comorbidities were included as modifiers of the 3-month models, and included in 4-year predictions. Results-Poststroke medical and psychiatric comorbidities significantly increased short-term poststroke mortality and morbidity. Severe periventricular white matter disease (PVWMD) was significantly associated with poor functional outcome at 3 months, independent of other factors, such as diabetes and age;inclusion of this imaging variable eliminated other traditional risk factors often found in stroke outcomes models. Outcome at 3 months was a significant predictor of long-term mortality and functional outcome. Black race was a predictor of 4-year mortality. Conclusions-We propose that predictive models for stroke outcome, as well as analysis of clinical trials, should include adjustment for comorbid conditions. The effects of PVWMD on short-term functional outcomes and black race on long-term mortality are findings that require confirmation.
AB - Background and Purpose-We sought to build models that address questions of interest to patients and families by predicting short-and long-term mortality and functional outcome after ischemic stroke, while allowing for risk restratification as comorbid events accumulate. Methods-A cohort of 451 ischemic stroke subjects in 1999 were interviewed during hospitalization, at 3 months, and at approximately 4 years. Medical records from the acute hospitalization were abstracted. All hospitalizations for 3 months poststroke were reviewed to ascertain medical and psychiatric comorbidities, which were categorized for analysis. Multivariable models were derived to predict mortality and functional outcome (modified Rankin Scale) at 3 months and 4 years. Comorbidities were included as modifiers of the 3-month models, and included in 4-year predictions. Results-Poststroke medical and psychiatric comorbidities significantly increased short-term poststroke mortality and morbidity. Severe periventricular white matter disease (PVWMD) was significantly associated with poor functional outcome at 3 months, independent of other factors, such as diabetes and age;inclusion of this imaging variable eliminated other traditional risk factors often found in stroke outcomes models. Outcome at 3 months was a significant predictor of long-term mortality and functional outcome. Black race was a predictor of 4-year mortality. Conclusions-We propose that predictive models for stroke outcome, as well as analysis of clinical trials, should include adjustment for comorbid conditions. The effects of PVWMD on short-term functional outcomes and black race on long-term mortality are findings that require confirmation.
KW - Ischemic stroke
KW - Models
KW - Outcomes
KW - Predicted models
KW - Race
KW - White matter disease
UR - http://www.scopus.com/inward/record.url?scp=60549117927&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=60549117927&partnerID=8YFLogxK
U2 - 10.1161/STROKEAHA.108.521906
DO - 10.1161/STROKEAHA.108.521906
M3 - Article
C2 - 19109548
AN - SCOPUS:60549117927
SN - 0039-2499
VL - 40
SP - 530
EP - 536
JO - Stroke
JF - Stroke
IS - 2
ER -